A Review of Radiomics in Predicting Therapeutic Response in Colorectal Liver Metastases: From Traditional to Artificial Intelligence Techniques.
Fatma AlshohoumiAbdullah Al-HamdaniRachid HedjamAbdulRahman AlAbdulsalamAdhari Abdullah AlZaabiPublished in: Healthcare (Basel, Switzerland) (2022)
An early evaluation of colorectal cancer liver metastasis (CRCLM) is crucial in determining treatment options that ultimately affect patient survival rates and outcomes. Radiomics (quantitative imaging features) have recently gained popularity in diagnostic and therapeutic strategies. Despite this, radiomics faces many challenges and limitations. This study sheds light on these limitations by reviewing the studies that used radiomics to predict therapeutic response in CRCLM. Despite radiomics' potential to enhance clinical decision-making, it lacks standardization. According to the results of this study, the instability of radiomics quantification is caused by changes in CT scan parameters used to obtain CT scans, lesion segmentation methods used for contouring liver metastases, feature extraction methods, and dataset size used for experimentation and validation. Accordingly, the study recommends combining radiomics with deep learning to improve prediction accuracy.
Keyphrases
- contrast enhanced
- deep learning
- artificial intelligence
- lymph node metastasis
- liver metastases
- computed tomography
- machine learning
- magnetic resonance imaging
- decision making
- high resolution
- squamous cell carcinoma
- magnetic resonance
- convolutional neural network
- big data
- positron emission tomography
- risk assessment
- photodynamic therapy
- weight loss
- metabolic syndrome
- mass spectrometry
- free survival